The next board meeting for VistaGen Therapeutics Inc is on 09 Sep 2025 for the purpose of Vistagen Therapeutics Inc Annual General Meeting for 2025See details
VistaGen Therapeutics Inc has a share price target of US$ 14, revenue growth forecast of 18.4%, and profit growth estimate of -27.7% for FY26, based on top 5 analyst calls.